Showing results (1-10 of 238) with videos related to
Sort By:
Pageof 24
Frontiers in Bioscience (Scholar Edition)|June 2, 2009
Calpain and the glutamatergic synapseShachee Doshi, David R LynchProceedings of the National Academy of Sciences of the United States of America|September 7, 2010
Axonal α7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutonsHong Lin, Stefano Vicini, Fu-Chun Hsu, et al.Scientific Reports|October 15, 2017
Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS-like phenotypes in the G93A mutant SOD1 mouse modelShachee Doshi, Preetika Gupta, Robert G KalbJournal of Neurochemistry|July 14, 2011
NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injuryDenise R Cook, Amy J Gleichman, Stephanie A Cross, et al.The Journal of Biological Chemistry|December 20, 2011
N-methyl-D-aspartate receptor mechanosensitivity is governed by C terminus of NR2B subunitPallab Singh, Shachee Doshi, Jennifer M Spaethling, et al.Free Radical Biology & Medicine|December 12, 2018
Neuropeptide signaling regulates the susceptibility of developing C. elegans to anoxiaShachee Doshi, Emma Price, Justin Landis, et al.Neuronal Signaling|May 28, 2021
Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventionsDavid R Lynch, Garrett FarmerJournal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 5, 2002
Practical approaches to neurogenetic diseaseDavid R Lynch, Jennifer FarmerExpert Opinion on Pharmacotherapy|April 15, 2024
Pharmacotherapeutic strategies for Friedreich Ataxia: a review of the available dataKatherine Gunther, David R LynchNeurodegenerative Disease Management|January 12, 2021
Omaveloxolone: potential new agent for Friedreich ataxiaDavid R Lynch, Joseph JohnsonPageof 24